Two Sigma Advisers’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-376,598
Closed -$62.7M 2237
2025
Q4
$62.7M Sell
376,598
-719,002
-66% -$120M 0.12% 164
2025
Q3
$215M Buy
1,095,600
+518,000
+90% +$85.2M 0.43% 54
2025
Q2
$52.2M Buy
577,600
+339,100
+142% +$26.8M 0.11% 180
2025
Q1
$14.2M Sell
238,500
-91,700
-28% -$8.48M 0.03% 430
2024
Q4
$43.7M Buy
330,200
+306,200
+1,276% +$28.7M 0.1% 184
2024
Q3
$1.26M Buy
+24,000
New +$1.13M ﹤0.01% 1305

Other funds holding ALAB

Two Sigma Advisers's ALAB Position: Q1 2026 in Review

Two Sigma Advisers sold out of Astera Labs (ALAB) in Q1 2026, closing a stake of 376,598 shares — an estimated $62.7M sold.

Two Sigma Advisers first reported a position in ALAB in Q3 2024 and held it in 6 quarters. The position peaked at $215M in Q3 2025. 708 funds tracked by Wall St. Rank hold ALAB as of Q1 2026.

  • Two Sigma Advisers reported no remaining Astera Labs position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Advisers sold 376,598 Astera Labs shares in Q1 2026, an estimated $62.7M.
  • Two Sigma Advisers first reported a position in Astera Labs in Q3 2024 and held it in 6 quarters.
  • Two Sigma Advisers's Astera Labs position peaked at $215M in Q3 2025.
  • 708 funds tracked by Wall St. Rank held Astera Labs as of Q1 2026.

Based on Two Sigma Advisers's 13F filing for Q1 2026.